Boston Scientific (BSX) Stock on December 10, 2025: Why Shares Are Sliding While the Growth Story Stays Intact
Boston Scientific shares closed at $92.53 on December 9, down 1.4% and marking a seventh straight decline, with trading volume spiking to 12.7 million shares. The stock sits about 15% below its September high despite strong Q3 results, including 20% year-over-year sales growth and adjusted EPS of $0.75, beating forecasts. Over the past year, BSX remains slightly positive and is up about 170% over five years.